search
English Bewerken
search EN

S.C.M. (Sharon) Essink MSc

Promovendus 
Bètawetenschappen
Farmaceutische wetenschappen
Pharmacoepi. and Clinical Pharmacol.
Pharmacoepi. and Clinical Pharmacol.

S.C.M. (Sharon) Essink MSc

Promovendus
Pharmacoepi. and Clinical Pharmacol.
s.c.m.essink@uu.nl
Profiel CV Publicaties Nevenwerkzaamheden Contact
Profiel CV Publicaties Nevenwerkzaamheden Contact
Onderzoeksthema's

Publicaties

2026

Wetenschappelijke publicaties

Lasys, T., Essink, S. C. M., Santa-Ana-Tellez, Y., Siiskonen, S. J., Weir, D. L., Zomerdijk, I. M., Groenwold, R. H. H., Bruin, M. L. D., & Gardarsdottir, H. (2026). Impact of policy measures targeting benzodiazepines and Benzodiazepine-related drugs in Lithuania: interrupted time series analysis. European Journal of Clinical Pharmacology, 82(3), Article 68. [DOI] [Portal]

2025

Wetenschappelijke publicaties

Essink, S. C. M., Zomerdijk, I. M., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Risk Minimisation Measures of Advanced Therapy Medicinal Products Authorised in the EU Between 2009 and 2023: A Cross-Sectional Study. Drug Safety, 48(9), 1005-1022. [DOI] [Portal]
Essink, S. C. M., Zomerdijk, I. M., Goedecke, T., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2025). Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies. Clinical Pharmacology and Therapeutics, 117(4), 1106-1114. [DOI] [Portal]

2023

Wetenschappelijke publicaties

Essink, S. C. M., Zomerdijk, I. M., Straus, S. M. J. M., Gardarsdottir, H., & De Bruin, M. L. (2023). Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021. Drug Safety, 46(10), 1007-1020. [DOI] [Repository]
Bekijk publicaties op de UU Research Portal

Direct naar

Diensten

Over de UU